Uploaded September 2023 | Updated September 2026, 2 weeks ago
Australian researchers have found venetoclax – an anti-cancer drug based on a groundbreaking research discovery at WEHI – can kill ‘silent’ HIV cells and delay reinfections.
The research was led by WEHI and The Peter Doherty Institute for Infection and Immunity (Doherty Institute) in Melbourne, Australia.
Hidden HIV cells are responsible for the virus permanently remaining in the body and cannot be treated by current therapy options. These hibernating, infected cells are the reason why people living with HIV require life-long treatment to suppress the virus.
WEHI’s Dr Phil Arandjelovic explains how the landmark study is being translated into a new clinical trial.
Read more: https://www.wehi.edu.au/news
Australian researchers have found venetoclax – an anti-cancer drug based on a groundbreaking research discovery at WEHI – can kill ‘silent’ HIV cells and delay reinfections.
The research was led by WEHI and The Peter Doherty Institute for Infection and Immunity (Doherty Institute) in Melbourne, Australia.
Hidden HIV cells are responsible for the virus permanently remaining in the body and cannot be treated by current therapy options. These hibernating, infected cells are the reason why people living with HIV require life-long treatment to suppress the virus.
WEHI’s Dr Phil Arandjelovic explains how the landmark study is being translated into a new clinical trial.
Read more: https://www.wehi.edu.au/news
